𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura: Outcome with plasma exchange

✍ Scribed by Dr. Andrew W. Roberts; E. Ann Gillett; Simon J. Fleming


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
420 KB
Volume
6
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

✦ Synopsis


A retrospective analysis was made of 14 consecutive adults with hemolytic uremic syndromeithrombotic thrombocytopenic purpura (HUSiTTP) who were treated with plasma exchange (PE). In six patients the disease was primary, whilst in eight HUSiTTP was considered secondary to an associated condition. Thirteen patients had renal involvement, six had central nervous system symptoms or signs, three had fever, and one had myocardial damage.

Twelve patients (86%) recovered. Four of these relapsed, but responded to further treatment. Two patients failed to respond and died. Hematological response occurred rapidly in survivors: thrombocytopenia resolved after a median of four exchanges, and hemolysis after a median of six. Four patients had a complete recovery, seven had residual mild end organ damage, and one had severe renal impairment.

PE was an effective treatment for both primary and secondary HUSITTP. The platelet count proved to be the earliest indicator of clinical outcome. Continuing follow-up of survivors is required because of the risk of relapse and the high incidence of end organ damage.


πŸ“œ SIMILAR VOLUMES


Thrombotic thrombocytopenic purpura-hemo
✍ James N. George; Ronald O. Gilcher; James W. Smith; Linda Chandler; Deanna Duval πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 41 KB πŸ‘ 1 views

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) is a clinical syndrome defined by the presence of thrombocytopenia and microangiopathic hemolytic anemia without a clinically apparent etiology. Patients may also have multiple other symptoms and signs including neurologic and r

Plasma exchange and vincristine in the t
✍ Victor A. Silva; Debra Frei-Lahr; Randy A. Brown; Geoffrey P. Herzig πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 457 KB

Hemolytic uremic syndrome/thrombotic thrornbocytopenic purpura (HUSITTP) is a rare and often fatal complication of bonc marrow transplantation (BMT). In this study. wc rcport eight such cases (seven allo and onc auto) treated with plasma exchanges (PE), vincristine (six paticnts), and discontinuatio

Lessons learned from the Oklahoma Thromb
✍ James N. George; Deirdra R. Terrell; Karen K. Swisher; Sara K. Vesely πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 114 KB

## Abstract The Oklahoma TTP‐HUS Registry provides a complete community perspective of thrombotic thrombocytopenic purpura (TTP). This is possible because plasma exchange is the essential treatment for TTP and the Oklahoma Blood Institute provides all plasma exchange procedures for a region encompa

Evaluation of women with clinically susp
✍ Johnny R. McMinn; James N. George πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 95 KB

## Abstract Thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome (TTP‐HUS) is more common in women, and commonly occurs during pregnancy and the immediate postpartum period. An important clinical issue is the distinction of TTP‐HUS from the more common obstetric complications, preeclampsia